Merck KgAA, has announced that the European Commission has granted approval for the new Pergoveris Pen, addressing an unmet medical...
Pergoveris is indicated for the stimulation of follicular development in adult women with severe LH and FSH deficiency. In clinical trials, these patients were defined by an endogenous serum LH level < 1.2 IU/L.
Pergoveris is indicated for the stimulation of follicular development in adult women with severe LH and FSH deficiency.